We are proud to support Network18 Group in launching ‘Netra Suraksha’ – India Against Diabetes.
As countries re-envision healthcare and rebuild economies, there is a unique opportunity for the industry and governments to strengthen healthcare systems by adopting evidence-led interventions.
Leaders of top Indian firms admit two months of grappling with a virus, the lockdown and an economic downturn has challenged every corporate rule in their book
Hyderabad: Switzerland-based pharmaceuticals manufacturer Novartis Pharma is increasing its focus on digitalisation and data.
Novartis' take on what to expect as tech transforms healthcare ...
For Meghdoot Deherkar, Head of Sales and Operations at Novartis India, the bottom line is profit. A steadfast salesperson with over two...
Under the shade of a spreading peepul tree, just 26 km from Varanasi, a few miles off NH31, Nayak Verma, the pradhan (headman) of Dhaura Hara village, watches as Prem Chand Maurya, an Arogya Health Shikshak (educator).
As the initiative completes its 10th year in India this year, Jawed Zia, Country President, Novartis India, says Arogya Parivar is a sustainable...
Global drug major Novartis has invested, expanded its research & development (R&D) capabilities in India. The global leader in biosimilars through its subsidiary Sandoz is assessing Indian market dynamics to launch its portfolio.
How Indian corporate firms have managed a successful 'Work From Home' culture, amid lockdown
Find contacts at Novartis for media and journalist inquiries
This site is intended for an audience in India